TabsDetailsBasic DetailsDate: Friday, September 8, 2017Medical Product: gadolinium-based contrast agent (GBCA)Health Outcome(s): exposure in pregnancyMeeting Details: View the Advisory Committee Meeting Materials hereAdditional InformationRelated Assessment(s): Gadolinium-Based Contrast Agents (GBCAs) Use in PregnancyRelated Link(s): Completed ARIA Assessments & Impact